Dongwha Pharm & Pfizer Pharmaceuticals Korea extend sales & distribution agreement of CNS products
Dongwha Pharm(CEO/President Kwang-Ryul Yoo) announced it has extended a sales and distribution agreement of Pfizer Pharmaceuticals Korea’s major CNS(central nervous system) products at Pfizer Tower on the 10th of April.
Dongwha Pharm and Pfizer Pharmaceuticals Korea made a partnership in 2015, a...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.